COVID-19 NEWS


Launch of FNR COVID-19 funding instrument

Following the fast-track FNR COVID-19 Call in 2020, the Luxembourg National Research Fund (FNR) has opened a new FNR COVID-19 funding instrument. There is no Call per se – projects can be submitted anytime from 21 April 2021 to 15 October 2021. Retained projects will be funded with up to 125,000 EUR for a maximum […]

COVID-19: Survey on the Socio-Economic impacts of the crisis

Phase 2 of the survey examines the long-term impacts on the experiences and expectations of residents and cross-border workers Within the framework of the Task Force Research Luxembourg, Luxembourg Institute of Socio-Economic Research (LISER) and the University of Luxembourg have decided to join their efforts to study the socio-economic impacts of the COVID-19 crisis in […]

COVID-19: CON-VINCE study enters homestretch

Originally launched in April 2020 under the aegis of the Research Luxembourg COVID-19 Taskforce, the CON-VINCE study aims to evaluate the prevalence and dynamics of the spread of COVID-19 within the Luxembourgish population, with a specific focus on asymptomatic and mildly symptomatic individuals. The last round of testing of the CON-VINCE participants is due to […]

COVID-19: The socio-economic impact of the pandemic and related (de)confinement measures in Luxembourg on individuals and households

Based off the results of Phase 1 of a large-scale survey, two major socio-economic impacts of the COVID-19 pandemic has been identified: one related to work and the other one related to daily life. The Socio-Economic Impact (SEI) project focuses on data collection to support research on the short- and medium-term impact of the COVID-19 pandemic […]

COVID-19: Predi-COVID study extended to children

Originally launched in April 2020 with the aim of identifying risk factors and biomarkers associated with COVID-19 severity in the adult population, Predi-COVID has now officially been extended to children. The study, coordinated by the Luxembourg Institute of Health (LIH) and carried out under the aegis of the Research Luxembourg COVID-19 Task Force, will particularly […]

COVID-19: Why is it possible to protect yourself and others by using vaccines and what are the underlying principles?

Pathogens such as viruses have always existed together with mankind. In this interview, Paul Heuschling, cell biologist and full Professor at the Department of Life Sciences and Medicine, explains the process of vaccine development. He elucidates how they can protect us due to immunisation and what are the underlying principles of the new mRNA vaccination […]

COVID-19: How can our psychological reactions during this pandemic, and in particular towards the vaccine be explained?

The COVID-19 pandemic imposes a high level of stress on all of us and negatively affects our mental health.How can our psychological reactions during this pandemic, and in particular towards the vaccine, be explained? Prof. Claus Vögele, Clinical and Health Psychologist at the University of Luxembourg, elucidates peoples’ psychological reactions– and underlines that we do […]

COVID-19: mass screening reveals significant transmission risk from asymptomatic carriers

Based on the results of the large-scale testing programme run in Luxembourg, researchers show that asymptomatic SARS-CoV-2 carriers represent an important vector for transmission. Large-scale testing for SARS-CoV-2 has been a topic of intense political and societal debate, the rationale for screening asymptomatic individuals having been in particular questioned. Nevertheless, whether asymptomatic carriers play an […]